MedTrace Logo

PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia

NCT04215822 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2020-01-03

No results posted yet for this study

Summary

The study aims to detect pattern of expression of PHF19 gene and EZH2 gene deletion in acute myeloid leukemia patients and detect their prognostic role on patients outcome.

Conditions

Interventions

DIAGNOSTIC_TEST

Cytogenetic analysis (FISH) for EZH2 gene deletion. -Real time PCR for PHF 19 gene expression.

Cytogenetic analysis (FISH) for EZH2 gene deletion. -Real time PCR for PHF 19 gene expression.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Somaia Abd El Rahman · Assiut University

Eligibility

Min Age
16 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-31
Primary Completion
2022-01-30
Completion
2022-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04215822 on ClinicalTrials.gov